Page last updated: 2024-10-27

fenofibrate and Hyperhomocysteinemia

fenofibrate has been researched along with Hyperhomocysteinemia in 8 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (

Research Excerpts

ExcerptRelevanceReference
" Recently, it has been shown that some of the most prescribed fibrates cause hyperhomocysteinemia, which itself has been recognised as a cardiovascular risk factor."4.82The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. ( Dierkes, J; Luley, C; Westphal, S, 2004)
"Patients with combined hyperlipidemia (n = 37) were randomized to receive 9 weeks of treatment with micronized fenofibrate 200 mg/day (F group) or fenofibrate 200 mg/day plus folic acid 10 mg/every other day (F+F group)."2.71Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. ( Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D, 2003)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foucher, C1
Brugère, L1
Ansquer, JC1
Dierkes, J3
Westphal, S3
Luley, C3
Thomas, C1
Mayer, O1
Simon, J1
Holubec, L1
Pikner, R1
Subrt, I1
Melenovsky, V1
Stulc, T1
Kozich, V1
Grauova, B1
Krijt, J1
Wichterle, D1
Haas, T1
Malik, J1
Hradec, J1
Ceska, R1
Bissonnette, R1
Treacy, E1
Rozen, R1
Boucher, B1
Cohn, JS1
Genest, J1

Reviews

3 reviews available for fenofibrate and Hyperhomocysteinemia

ArticleYear
Fenofibrate, homocysteine and renal function.
    Current vascular pharmacology, 2010, Volume: 8, Issue:5

    Topics: Animals; Biomarkers; Creatinine; Disease Progression; Dyslipidemias; Fenofibrate; Glomerular Filtrat

2010
Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management.
    Drug safety, 2003, Volume: 26, Issue:2

    Topics: Arteriosclerosis; Fenofibrate; Folic Acid; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Kidne

2003
The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
    Expert opinion on drug safety, 2004, Volume: 3, Issue:2

    Topics: Fenofibrate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Niac

2004

Trials

4 trials available for fenofibrate and Hyperhomocysteinemia

ArticleYear
Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration.
    European journal of clinical pharmacology, 2003, Volume: 59, Issue:5-6

    Topics: Aged; Anticholesteremic Agents; Cross-Over Studies; Fatty Acids, Monounsaturated; Female; Fenofibrat

2003
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
    American heart journal, 2003, Volume: 146, Issue:1

    Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomoc

2003
Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
    Lancet (London, England), 1999, Jul-17, Volume: 354, Issue:9174

    Topics: Adult; Bezafibrate; Chromatography, High Pressure Liquid; Fenofibrate; Folic Acid; Hematinics; Homoc

1999
Fenofibrate raises plasma homocysteine levels in the fasted and fed states.
    Atherosclerosis, 2001, Volume: 155, Issue:2

    Topics: Adult; Coronary Artery Disease; Dairy Products; Dietary Fats; Double-Blind Method; Eating; Fasting;

2001

Other Studies

1 other study available for fenofibrate and Hyperhomocysteinemia

ArticleYear
[Letter to the editor by X. Roblin et al., Influence of hypolipemic treatment on homocysteinemia].
    La Revue de medecine interne, 2003, Volume: 24, Issue:5

    Topics: Creatinine; Fenofibrate; Glomerular Filtration Rate; Humans; Hyperhomocysteinemia; Hypolipidemic Age

2003